Essential Pharmacy Compounding LLC

Form 483 issued July 27, 2017 · Omaha, Nebraska

Inspection
Jul 10, 2017
Investigator
Kellia N. Hicks
Observations
3
Pages
2
FEI number
3003718003

In short: On July 27, 2017, FDA issued a Form 483 with 3 observations to Essential Pharmacy Compounding LLC in Omaha, Nebraska (FEI 3003718003) after an inspection that ran Jul 10, 2017. The investigator was Kellia N. Hicks. Most observations concern production and facilities & equipment; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

2 of 3 observations on this 483 concern production.

Production2
Facilities & equipment1

Most cited: 21 CFR 211.113 (2×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Equipment, materials, and/or supplies are not cleaned prior to initiating aseptic production after the…

  2. 02

    Personnel engaged in aseptic processing failed to prevent cross-contamination on the working surface of the ISO…

  3. 03

    Non-sterile disinfecting agents are used in the aseptic…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Essential Pharmacy Compounding LLC?

FDA listed 3 observations on this Form 483, mostly about production and facilities & equipment. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Essential Pharmacy Compounding LLC?

Kellia N. Hicks is named on this Form 483, for the inspection of Jul 10, 2017. Each investigator has a profile showing what they cite most.

When was Essential Pharmacy Compounding LLC inspected by FDA?

The inspection ran Jul 10, 2017, and the Form 483 is dated July 27, 2017.

How do I get the full Form 483 for Essential Pharmacy Compounding LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free